|2.||Lichen Planus (Lichen Ruber Planus)
|4.||Psoriasis (Pustulosis Palmaris et Plantaris)
|5.||Rosacea (Acne Rosacea)
|1.||Sundberg, John P: 16 articles (01/2014 - 08/2002)|
|2.||Tosti, Antonella: 12 articles (02/2015 - 07/2003)|
|3.||Shapiro, Jerry: 9 articles (08/2015 - 03/2003)|
|4.||Freyschmidt-Paul, Pia: 9 articles (10/2013 - 07/2002)|
|5.||McElwee, Kevin J: 9 articles (02/2013 - 06/2002)|
|6.||Gilhar, Amos: 8 articles (01/2015 - 07/2002)|
|7.||Ito, Taisuke: 8 articles (11/2014 - 02/2004)|
|8.||Price, Vera H: 8 articles (02/2013 - 10/2003)|
|9.||Freyschmidt-Paul, P: 8 articles (06/2007 - 08/2000)|
|10.||Paus, Ralf: 7 articles (01/2015 - 02/2004)|
|1.||Minoxidil (Rogaine)FDA LinkGeneric
03/01/2004 - "An immunologic mechanism for the therapeutic efficacy of minoxidil in alopecia areata."
03/01/1989 - "Minoxidil is a relatively safe treatment for extensive alopecia areata and may be effective in the treatment of some cases of recalcitrant disease."
11/01/1987 - "These findings suggest that improved preparations of topical minoxidil, when used as a single therapeutic agent, are unlikely to be cosmetically effective in the majority of patients with severe alopecia areata."
02/01/1986 - "The results strongly suggest a dose-response effect for topical minoxidil treatment of alopecia areata and the importance of exploring modifications in dosing and delivery systems to enhance therapeutic efficacy."
11/01/1993 - "This study was designed to evaluate the efficacy of DPCP alone or in combination with topical 5% minoxidil for the treatment of chronic severe alopecia areata. "
01/01/2010 - "Diphencyprone is a contact sensitizer used to treat dermatological conditions resulting from as altered immunological state, such as extensive alopecia areata, being partially effective and safe. "
11/01/2015 - "Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients."
09/01/2014 - "Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients."
09/01/2012 - "The safety and efficacy of diphencyprone for the treatment of alopecia areata in children."
01/01/2009 - "The efficacy of topical diphencyprone in the treatment of alopecia areata."
|3.||Adrenal Cortex Hormones (Corticosteroids)IBA
10/01/1998 - "Oral corticosteroids may be effective in the treatment of severe alopecia areata (AA), but the side effects of prolonged therapy limit their use. "
08/01/1998 - "Systemic corticosteroids have been demonstrated as an effective treatment of severe alopecia areata. "
09/01/1963 - "[RELATIVE EFFICACY OF THE "IN LOCO" INJECTION OF DIFFERENT CORTICOIDS IN ALOPECIA AREATA]."
11/01/2006 - "Clinical efficacy of topical corticosteroids in alopecia areata (AA) is still controversial. "
02/01/2005 - "Systemic corticosteroids administered as pulse therapy have been found helpful in a wide array of diseases including alopecia areata (AA). "
|4.||Betamethasone (Celestone)FDA Link
01/01/2007 - "The present study showed that the use of garlic gel significantly added to the therapeutic efficacy of topical betamethasone valerate in alopecia areata and that it can be an effective adjunctive topical therapy for alopecia areata."
11/01/2004 - "Oral mini-pulse therapy with betamethasone is a safe and effective therapeutic modality for extensive alopecia areata."
01/01/2007 - "Combination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: a double-blind randomized controlled study."
11/01/2004 - "Extensive alopecia areata treated with betamethasone oral mini-pulse therapy: an open uncontrolled study."
11/01/2006 - "Twice weekly 5 mg betamethasone oral pulse therapy in the treatment of alopecia areata."
07/01/1999 - "In order to test the assumed analogy with human alopecia areata, we investigated the efficacy of treatment with the contact allergen squaric acid dibutylester. "
08/01/2000 - "In this study we examined the effects of squaric acid dibutylester treatment on hair follicles and the associated leukocyte infiltrate in alopecia areata mice by light and transmission electron microscopic analysis. "
07/01/1999 - "Immunohistomorphometric studies revealed that treatment with squaric acid dibutylester increased the CD4+/CD8+ ratio from approximately 1:2 in untreated alopecia areata to 1:1 in treated alopecia areata. "
11/01/1996 - "Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study."
09/01/2015 - "Squaric acid sensitization is not required for response in the treatment of alopecia areata."
|6.||squaric acid dibutyl esterIBA
11/01/1996 - "In this prospective, double-sided patient-controlled therapeutical trial involving 20 patients with alopecia areata, we investigated the efficacy of topical acid dibutylester (SADBE) in the treatment of alopecia areata. "
01/01/1985 - "A controlled trial of contact allergen therapy of alopecia areata (AA) using squaric acid dibutyl ester (SADBE) was performed on 17 patients. "
09/01/2015 - "This is a retrospective review of the use of SADBE in the treatment of alopecia areata in 14 patients. "
03/01/2006 - "During a 4-year period, 70 patients of alopecia areata, unresponsive to conventional therapies, were treated with SADBE for a period of 4 months and thereafter depending on the response with initial therapy. "
03/01/2006 - "Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome."
|7.||Tacrolimus (Prograf)FDA LinkGeneric
04/01/2004 - "Therapeutic studies in the C3H/HeJ mouse and the DEBR suggest that alopecia areata can be treated by topical tacrolimus but treatment in humans may only be successful after development of an improved vehicle that facilitates penetration of tacrolimus down to the hair bulb. "
11/01/2002 - "Is topical tacrolimus effective in alopecia areata universalis?"
10/01/1997 - "We elected to examine the efficacy of the topically applied immunosuppressive agent FK506 (Prograf) in the treatment of alopecia areata (AA) using the Dundee experimental bald rat (DEBR) model. "
01/01/2005 - "Eleven patients with alopecia areata affecting 10% to 75% of the scalp, average duration 6 years, had no terminal hair growth in response to tacrolimus ointment 0.1% applied twice daily for 24 weeks. "
01/01/2005 - "Topical tacrolimus in alopecia areata."
|8.||latanoprost (Xalatan)FDA Link
04/01/2010 - "The aim of this study was to test the efficacy of latanoprost in eyelash alopecia areata (AA). "
11/01/2009 - "The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows."
12/01/2005 - "Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata."
11/01/2009 - "In an experimental study, 26 patients with symmetrical eyelash and eyebrow alopecia areata were treated over 4 months with topical latanoprost for one side and the other side was not treated with any drug. "
11/01/2009 - "Based on our results, topical latanoprost has no efficacy in the treatment of alopecia areata. "
|9.||Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
11/01/2002 - "The majority of patients with limited alopecia areata (82.1%) had more than 50% improvement with intralesional triamcinolone acetonide after 3 months. "
10/01/2009 - "Intralesional triamcinolone acetonide is a safe and effective treatment for patients with extensive alopecia areata. "
05/01/2013 - "To evaluate the efficacy of intralesional triamcinolone acetonide in the treatment of alopecia areata and to use dermoscopy to identify signs of early clinical response and adverse effects. "
11/01/2015 - "There is insufficient data in the literature concerning optimal intralesional kenalog (ILK) dosing for the treatment of alopecia areata (AA). "
08/01/2015 - "Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study."
|10.||Prednisolone (Predate)FDA LinkGeneric
11/01/2009 - "Although the exact etiology of alopecia areata is still unknown, systemic prednisolone treatment seem to be effective in early stages but significant side effects may occur leading to discontinuation of treatment. "
11/01/2009 - "A series of three monthly courses of medium-dose prednisolone pulse therapy is effective and well tolerated in most patients with active, multifocal alopecia areata. "
11/01/2009 - "Evaluation of efficacy and saftety of a short-term medium-dose pulse prednisolone treatment in alopecia areata. "
11/01/2009 - "Medium-dose prednisolone pulse therapy in alopecia areata."
12/01/2005 - "Is oral pulsed prednisolone useful in alopecia areata? "
10/01/2002 - "Topical immunotherapy is effective for severe alopecia areata. "
09/01/2001 - "Topical immunotherapy with a contact allergen is effective in alopecia areata (AA). "
03/01/2013 - "Topical immunotherapy has recently been found useful in the treatment of chronic and extensive Alopecia Areata (AA). "
09/01/2015 - "Contact immunotherapy-resistant alopecia areata totalis/universalis reactive to topical corticosteroid."
04/01/2015 - "Some patients with chronic extensive alopecia areata (AA) may be refractory to topical immunotherapy. "
09/01/2009 - "In this study we assessed the efficacy of 308-nm Excimer laser in the treatment of alopecia areata in children. "
01/01/2015 - "Some studies have reported the use of 308-nm excimer laser therapy for treating alopecia areata (AA); however, the effectiveness of this therapy on a theoretical basis has not yet been comparatively analyzed. "
12/01/2007 - "To study the effect of the 308-nm excimer laser in the treatment of alopecia areata. "
01/01/2004 - "Further studies with greater numbers are needed to assess its potential more precisely and evaluate the excimer laser in treating alopecia areata."
01/01/2015 - "Effectiveness of 308-nm Excimer Laser Therapy in Treating Alopecia Areata, Determined by Examining the Treated Sides of Selected Alopecic Patches."
|3.||Drug Therapy (Chemotherapy)
12/01/2013 - "Few dermatologic conditions carry as much anxiety and emotional distress as hair loss resulting from a disease condition such as alopecia areata or as a result of cytotoxic drug treatment, e.g., after chemotherapy. "
01/01/2003 - "Recurring chemotherapy-associated alopecia areata: case report and literature review."
01/01/1992 - "Four months after the completion of chemotherapy, the patient had normal hair regrowth with no evidence of alopecia areata. "
01/01/1992 - "Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy."
01/01/2015 - "This methodology was tested in mouse models of chemotherapy-induced alopecia, alopecia areata and alopecia from waxing. "
|4.||Homologous Transplantation (Allograft)
11/01/2012 - "Alopecia areata in a composite tissue (hand) allograft recipient following graft rejection."
02/01/2004 - "These agents are promising candidates for immune privilege restoration and for suppressing MHC class I expression where this is clinically desired (eg, in alopecia areata, multiple sclerosis, autoimmune uveitis, mumps orchitis, and fetal or allograft rejection)."
01/01/1986 - "Cyclosporin-A-induced hair growth in human renal allograft recipients and alopecia areata."
01/01/2002 - "It has also been suggested that topical tacrolimus is useful in the treatment of alopecia areata, erosive lichen planus, isolated ichthyosis linearis circumflexa, steroid-induced rosacea, and in the prevention of allograft rejection, however more clinical trials need to be performed."
11/01/1998 - "The results show aromatherapy to be a safe and effective treatment for alopecia areata. "
11/01/1998 - "To investigate the efficacy of aromatherapy in the treatment of patients with alopecia areata. "
05/01/1999 - "Randomized trial of aromatherapy: successful treatment for alopecia areata."